Last A$0.09 AUD
Change Today +0.001 / 1.14%
Volume 913.8K
NEU On Other Exchanges
Symbol
Exchange
OTC US
As of 10:31 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for neuren pharmaceuticals ltd (NEU)

Year over year, Neuren Pharmaceuticals Limited has seen their bottom line shrink from a loss of $6.4M NZD to an even larger loss of $12.3M NZD despite an increase in revenues from $5.3M NZD to $5.7M NZD. An increase in the percentage of sales devoted to cost of goods sold from 154.32% to 172.34% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of New Zealand Dollars
As of:Dec 31
2010
NZD
Dec 31
2011
NZD
Dec 31
2012
NZD
Dec 31
2013
NZD
4 Year
Trend
Revenues6.14.25.35.7
TOTAL REVENUES6.14.25.35.7
Cost of Goods Sold9.67.28.29.8
GROSS PROFIT-3.5-3.0-2.9-4.1
Selling General & Admin Expenses, Total2.33.23.33.2
Depreciation & Amortization, Total0.50.50.50.5
OTHER OPERATING EXPENSES, TOTAL2.83.73.73.7
OPERATING INCOME-6.3-6.7-6.6-7.8
Interest Expense0.00.0----
Interest and Investment Income0.10.20.30.2
NET INTEREST EXPENSE0.10.20.30.2
Currency Exchange Gains (Loss)-0.10.3-0.2-1.6
EBT, EXCLUDING UNUSUAL ITEMS-6.3-6.2-6.5-9.2
Gain (Loss) on Sale of Assets-0.2------
Other Unusual Items, Total-------3.2
EBT, INCLUDING UNUSUAL ITEMS-6.6-6.2-6.5-12.3
Minority Interest in Earnings0.10.10.10.0
Earnings from Continuing Operations-6.6-6.2-6.5-12.3
NET INCOME-6.4-6.1-6.4-12.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-6.4-6.1-6.4-12.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-6.4-6.1-6.4-12.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEU:AU A$0.09 AUD +0.001

NEU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEU.
View Industry Companies
 

Industry Analysis

NEU

Industry Average

Valuation NEU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.7x
Price/Book 5.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUREN PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.